Sarah Kang

443 citations
5 papers · 309 indexed · 1 hit paper · h-index 4
Topics
interferon and immune responses (1 paper)Alkaloids: synthesis and pharmacology (1 paper)Enhanced Recovery After Surgery (1 paper)

In The Last Decade

Sarah Kang

5 papers receiving 304 citations

Hit Papers

Metformin inhibition of mitochondrial ATP and DNA synthes...2021202620222024202150100150200250

Peers

Sarah Kang
Comparison fields: 5 of 75
  • Molecular Biology 195
  • Immunology 98
  • Epidemiology 53
  • Infectious Diseases 40
  • Surgery 33
Replace Hongfeng Yang with:
Hongfeng Yang China
Abishai Dominic United States
Xiaoping Peng China
Vinodkumar Singh United States
Milijana Janjusevic Italy
Yijun Dong China
Aparajit B. Dey India
Yi Tao Chan United States
Ermina Bach Denmark
Sarah Kang relative to Hongfeng Yang China Hongfeng Yang's profile →
Citations per field
00.5×1.6×
Hongfeng Yang · 1×
Citations per year

Countries citing papers authored by Sarah Kang

Since Specialization
Citations

This map shows the geographic impact of Sarah Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Kang more than expected).

Fields of papers citing papers by Sarah Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Kang. The network helps show where Sarah Kang may publish in the future.

Co-authorship network of co-authors of Sarah Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Kang. A scholar is included among the top collaborators of Sarah Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Kang. Sarah Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 13
2 6
3
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammationbreakdown →
281
4 2
5 7

About Sarah Kang

Sarah Kang is a scholar working on Critical Care and Intensive Care Medicine, Pharmacology and Immunology, having authored 5 papers that have together received 309 indexed citations. Recurring topics across this work include interferon and immune responses (1 paper), Alkaloids: synthesis and pharmacology (1 paper) and Enhanced Recovery After Surgery (1 paper). The work is most often cited by research in Immunology (98 citations), Biological Psychiatry (8 citations) and Molecular Biology (195 citations). Sarah Kang has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Elsa Sánchez‐López, Yuan Liu, A. Nilsson, Germán Rodrigo Alemán-Muench, Hongxu Xian, Gavin Lewis, Moshe Arditi, Timothy R. Crother, Yi Zhang and John R. Teijaro. Their work appears in journals such as Immunity, Frontiers in Immunology and Nanophotonics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026